RIGEL PHARMACEUTICALS, INC. Inventory, Raw Materials, Gross
RIGEL PHARMACEUTICALS, INC. (RIGL) had Inventory, Raw Materials, Gross of $7.23 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:InventoryRawMaterials · last filed 2026-08-04
- 2026-06-30: Inventory, Raw Materials, Gross $7.23M.
- 2026-03-31: Inventory, Raw Materials, Gross $3.43M.
- 2025-12-31: Inventory, Raw Materials, Gross $4.51M.
- 2025-09-30: Inventory, Raw Materials, Gross $6.95M.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2026-06-30 | $7.23M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $3.43M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $4.51M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $6.95M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $9.63M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.08M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.08M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.57M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.15M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $3.92M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.61M 10-K · filed 2025-03-04 |
| 2023-09-30 | $5.70M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.88M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $6.91M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $4.55M 10-K · filed 2024-03-05 |
| 2022-09-30 | $4.55M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.55M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $4.55M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $5.14M 10-K · filed 2023-03-07 |
| 2021-09-30 | $5.14M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $5.14M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $5.14M 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |